Rare diseases
Investigational molecules
Locations
Study of GHZ339 for treatment of moderate to severe atopic dermatitis
GermanyLong-term safety study of GD2IL18CART treatment in patients with neuroblastoma, osteosarcoma, Ewing sarcoma, or advanced breast cancer
GermanyStudy of drug combination therapy for prevention of recurrent stroke in patients with acute ischemic stroke and atrial fibrillation
GermanyStudy of intestinal gel containing levodopa, carbidopa and entacapone to treat motor and behavioral symptoms in patients with Parkinson's disease
GermanyStudy of BMS-986368 to treat muscle stiffness in people with Multiple Sclerosis
GermanyStudy of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer
GermanyStudy of VHB937 to evaluate its effects on cognition and function in people with early Alzheimer's Disease over 72 weeks
GermanyStudy of Darolutamide and Testosterone for Patients with Advanced Prostate Cancer Resistant to Standard Hormone Therapy
GermanyStudy Comparing Golcadomide and Rituximab with Other Treatments for Patients with Relapsed or Refractory Follicular Lymphoma
GermanyStudy of Temozolomide, Topotecan, Bevacizumab, Irinotecan and Dinutuximab Beta in Patients with High-Risk Relapsed Neuroblastoma
GermanyEffectiveness and Safety of Abrocitinib in Children 6 to Under 12 Years with Moderate-to-Severe Atopic Dermatitis
GermanyStudy of Trastuzumab Deruxtecan, Rilvegostomig, and Pembrolizumab for Advanced or Recurrent Endometrial Cancer in HER2-Positive Patients
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
